Document is current
Any future updates will be listed below
-
Authors
Lee, Ha Won
O’Reilly, Carla
Beckett, Alex N.
Currier, Duane G.
Chen, Taosheng
DeRenzo, Christopher http://orcid.org/0000-0001-6127-4601
-
Funding
Funding for this research was provided by:
American Lebanese Syrian Associated Charities
Assisi Foundation of Memphis
- License Information
-
More Information
Article History
Received: 16 June 2023
Accepted: 21 March 2024
First Online: 1 April 2024
Declarations
:
: Human PBMCs were obtained from whole blood of healthy donors under an institutional review board approved protocol at St. Jude Children’s Research Hospital, after informed consent was obtained in accordance with the Declaration of Helsinki, or from de-identified elutriation chambers of leukapheresis products obtained from the St. Jude donor center. The human blood donor protocol was approved by the St. Jude Children’s Research Hospital Institutional Review Board. The protocol ID is pro00008053. Participants gave informed consent to participate in the study before taking part.
: Not applicable.
: CD is a co-inventor on patent applications in the field of T cell therapy for cancer. All other authors declare no competing interests.
